MAE JANIGA: Open Payments
NPI 1891263497 · GEORGETOWN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 55 payments from 19 companies in 2025. Trend: 2023 $740 · 2024 $1,114 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $237 |
| Amgen Inc. | 6 | $165 |
| AstraZeneca Pharmaceuticals LP | 7 | $108 |
| SANOFI-AVENTIS U.S. LLC | 3 | $93 |
| Lilly USA, LLC | 2 | $66 |
| Abbott Laboratories | 3 | $58 |
| PFIZER INC. | 3 | $49 |
| QOL Medical, LLC | 3 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Dexcom, Inc. | 2 | $43 |
Products named: Ozempic, OTEZLA, TZIELD, MOUNJARO, Wegovy, FARXIGA, FREESTYLE LIBRE 3, PREVNAR 20.
Industry payments across SC — which companies pay providers there.
